BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8410992)

  • 1. Renin inhibitors containing a pyridyl amino diol derived C-terminus.
    Heitsch H; Henning R; Kleemann HW; Linz W; Nickel WU; Ruppert D; Urbach H; Wagner A
    J Med Chem; 1993 Sep; 36(19):2788-800. PubMed ID: 8410992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the renin inhibitor N-[N-(3-(4-amino-1-piperidinyl-carbonyl)-2(R)-benzylpropionyl)-L- histid inyl] -(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6(2-pyridyl)-hexane-2-amide acetate in anesthetized rhesus monkeys.
    Linz W; Heitsch H; Henning R; Jung W; Kleemann HW; Nickel WU; Ruppert D; Urbach H; Wagner A; Schölkens BA
    Arzneimittelforschung; 1994 Jul; 44(7):815-20. PubMed ID: 7945514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogue.
    Atsuumi S; Nakano M; Koike Y; Tanaka S; Funabashi H; Matsuyama K; Nakano M; Sawasaki Y; Funabashi K; Morishima H
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3214-21. PubMed ID: 1294323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
    Schaffer LW; Schorn TW; Winquist RJ; Strouse JF; Payne L; Chakravarty PK; de Laszlo SE; tenBroeke J; Veber DF; Greenlee WJ
    J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitors containing alpha-heteroatom amino acids as P2 residues.
    Repine JT; Kaltenbronn JS; Doherty AM; Hamby JM; Himmelsbach RJ; Kornberg BE; Taylor MD; Lunney EA; Humblet C; Rapundalo ST
    J Med Chem; 1992 Mar; 35(6):1032-42. PubMed ID: 1552498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives.
    Bradbury RH; Major JS; Oldham AA; Rivett JE; Roberts DA; Slater AM; Timms D; Waterson D
    J Med Chem; 1990 Sep; 33(9):2335-42. PubMed ID: 2118184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 3.1 Synthesis and biological properties of aminodeoxystatine and difluorostatone derivatives.
    Bradbury RH; Rivett JE
    J Med Chem; 1991 Jan; 34(1):151-7. PubMed ID: 1992113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of potent substrate-analogue inhibitors of canine renin.
    Hui KY; Siragy HM; Haber E
    Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency.
    Bock MG; DiPardo RM; Evans BE; Freidinger RM; Rittle KE; Payne LS; Boger J; Whitter WL; LaMont BI; Ulm EH
    J Med Chem; 1988 Oct; 31(10):1918-23. PubMed ID: 3050088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
    Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
    J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a potent inhibitor of subprimate and primate renins.
    Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J
    J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CP-71,362: a pentapeptide renin inhibitor selective for the canine enzyme.
    Mangiapane ML; MacAndrew JT; Ellery SS; Smith AH; Purcell IM; Kleinman EF; Holt WF; Murphy WR
    Clin Exp Hypertens; 1994 Jul; 16(4):507-33. PubMed ID: 7920458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel renin inhibitors containing the amino acid statine.
    Boger J; Lohr NS; Ulm EH; Poe M; Blaine EH; Fanelli GM; Lin TY; Payne LS; Schorn TW; LaMont BI; Vassil TC; Stabilito II; Veber DF; Rich DH; Bopari AS
    Nature; 1983 May 5-11; 303(5912):81-4. PubMed ID: 6341856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin inhibitors containing C-termini derived from mercaptoheterocycles.
    Ashton WT; Cantone CL; Meurer LC; Tolman RL; Greenlee WJ; Patchett AA; Lynch RJ; Schorn TW; Strouse JF; Siegl PK
    J Med Chem; 1992 May; 35(11):2103-12. PubMed ID: 1597860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of some transition-state inhibitors of human renin.
    Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
    J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
    Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
    J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.
    Patt WC; Hamilton HW; Taylor MD; Ryan MJ; Taylor DG; Connolly CJ; Doherty AM; Klutchko SR; Sircar I; Steinbaugh BA
    J Med Chem; 1992 Jul; 35(14):2562-72. PubMed ID: 1635057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel renin inhibitors containing (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol fragment as a transition-state mimic at the P1-P1' cleavage site.
    Yamada Y; Ando K; Ikemoto Y; Tada H; Shirakawa E; Inagaki E; Shibata S; Nakamura I; Hayashi Y; Ikegami K; Uchida I
    Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1631-41. PubMed ID: 9353891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water-soluble renin inhibitors: design of a subnanomolar inhibitor with a prolonged duration of action.
    Rosenberg SH; Woods KW; Sham HL; Kleinert HD; Martin DL; Stein H; Cohen J; Egan DA; Bopp B; Merits I
    J Med Chem; 1990 Jul; 33(7):1962-9. PubMed ID: 2194033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.